Understanding the synergy between these related aminopeptidases is crucial for uncovering alternative pharmaceutical targets to harness and modulate immune factors while minimizing the risk of system-wide pathologies in the treatment of cancers and autoimmune conditions. The gene discussed is CPQ; the disease is cancer.